Mode
Text Size
Log in / Sign up
Phase 1 N=23 Randomized Diagnostic

Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases

Gastrointestinal and Gynecologic Malignancies

Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Jan 2021
Primary outcome: Primary: Rate of Detectable Peritoneal Metastases — 0; 2 percentage of lesions

Study Design & Population

Study type
Interventional
Phase
Phase 1
Interventions
Laparoscopic narrow band imaging (Device); Standard white-light laparoscopy (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Lahey Clinic
Primary completion
Sep 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Rate of Detectable Peritoneal Metastases
0; 2

Summary

Adult patients evaluated at Lahey Clinic with known or suspected gastrointestinal or gynecologic malignancies and with an indication for diagnostic laparoscopy will be offered participation in the study. The proposed study is a randomized, controlled feasibility trial with crossover design. The study's aim is to evaluate the effectiveness of laparoscopic narrow band imaging (NBI) compared to standard white-light laparoscopy for detection of peritoneal cancer metastases. Study patients will undergo laparoscopic evaluation of the peritoneal cavity using a routine white-light videolaparoscope with the capability of NBI. The order of white-light and NBI laparoscopy will be randomized for each patient (crossover design). Frozen-section histopathology biopsies will be retrieved of all suspicious-appearing abnormalities using best clinical practices. The number of detected peritoneal metastases will be compared between each diagnostic laparoscopy technique. To gauge the rate of potentially missed metastases, peritoneal cancer recurrence will be surveyed through a 1-year follow-up.

Eligibility Criteria

Inclusion Criteria

  • adult patients
  • diagnosis or suspicion of malignancy of the gastrointestinal or gynecologic tract

Exclusion Criteria

  • clinical contraindication to diagnostic laparoscopy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01944930). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search